A detailed history of Principal Securities, Inc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 342 shares of VKTX stock, worth $11,604. This represents 0.0% of its overall portfolio holdings.

Number of Shares
342
Previous 206 66.02%
Holding current value
$11,604
Previous $13 Million 5.52%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$38.28 - $78.03 $5,206 - $10,612
136 Added 66.02%
342 $13.8 Million
Q3 2024

Oct 28, 2024

BUY
$49.84 - $70.47 $8,722 - $12,332
175 Added 564.52%
206 $13 Million
Q2 2024

Jul 31, 2024

SELL
$47.39 - $80.2 $473 - $802
-10 Reduced 24.39%
31 $1.64 Million
Q1 2024

May 10, 2024

BUY
$17.4 - $94.5 $713 - $3,874
41 New
41 $3.36 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $2.6B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.